Abstract : With interest we read the article by Thomas et al. about a 44 year old
female with MELAS syndrome due to the m.3243ANG mutation,
which manifested cardiologically as hypertrophic cardiomyopathy and
episodes of supraventricular tachycardia requiring atenolol [1]. We
have the following comments and concerns
